CANNABIS POLAND AB ZY-10 (8TE) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.304x

Based on the latest financial reports, CANNABIS POLAND AB ZY-10 (8TE) has a cash flow conversion efficiency ratio of -0.304x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-463.42K ≈ $-541.78K USD) by net assets (€1.52 Million ≈ $1.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CANNABIS POLAND AB ZY-10 balance sheet independence to measure how much of total assets are equity-financed.

CANNABIS POLAND AB ZY-10 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how CANNABIS POLAND AB ZY-10's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore how well can CANNABIS POLAND AB ZY-10 service its debt to assess how comfortably operating cash covers total debt obligations.

CANNABIS POLAND AB ZY-10 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CANNABIS POLAND AB ZY-10 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
True North Gems Inc V:TGX	0.001x
Quartix Holdings Plc LSE:QTX	0.121x
Pineapple Financial Inc. NYSE:PAPL	0.471x
GO2 People Ltd AU:GO2	-0.007x
KEFI Gold and Copper Plc LSE:KEFI	-0.170x
Wang & Lee Group, Inc. Ordinary Shares NASDAQ:WLGS	0.051x
Nusantara Inti Corpora Tbk JK:UNIT	-0.084x
Macfarlane Group PLC LSE:MACF	0.103x

Annual Cash Flow Conversion Efficiency for CANNABIS POLAND AB ZY-10 (2021–2025)

The table below shows the annual cash flow conversion efficiency of CANNABIS POLAND AB ZY-10 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see CANNABIS POLAND AB ZY-10 stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€1.52 Million ≈ $1.78 Million	€-2.17 Million ≈ $-2.54 Million	-1.426x	-138.71%
2024-12-31	€3.54 Million ≈ $4.14 Million	€-2.11 Million ≈ $-2.47 Million	-0.598x	+37.85%
2023-12-31	€1.36 Million ≈ $1.58 Million	€-1.30 Million ≈ $-1.52 Million	-0.961x	+13.37%
2022-12-31	€321.96K ≈ $376.41K	€-357.28K ≈ $-417.70K	-1.110x	+42.68%
2021-12-31	€480.84K ≈ $562.15K	€-930.97K ≈ $-1.09 Million	-1.936x	--

About CANNABIS POLAND AB ZY-10

F:8TE Germany Drug Manufacturers - Specialty & Generic

Market Cap

$1.40 Million

€1.20 Million EUR

Market Cap Rank

#30326 Global

#2651 in Germany

Share Price

€0.02

Change (1 day)

+5.26%

52-Week Range

€0.02 - €0.07

All Time High

€0.69